Outcome
    Moderate Evidence

    St. Johns Wort for Seasonal Mood Support

    St John's Wort works for mild to moderate depression but interacts with an alarming number of medications.

    Overview

    St John's wort has the largest evidence base of any herbal antidepressant. The Cochrane review of Hypericum extracts in major depression concluded it was superior to placebo and similarly effective to standard antidepressants, with fewer adverse effects, though trials from German-speaking countries reported notably larger effects than those conducted elsewhere. Applied to seasonal mood, the extrapolation is reasonable but indirect. The trials were in major depressive disorder rather than seasonal presentations, and the few studies specifically in seasonal affective disorder were small and often combined with light therapy.

    Verdict

    Likely effective

    Cochrane-level evidence for antidepressant efficacy comparable to standard drugs with better tolerability. Seasonal-specific trials are small, and the interaction profile is the most serious of any common supplement.

    Efficacy is not the constraint with this herb. The drug interaction profile is, and it is severe enough that a full medication review should happen before anyone starts, not after.

    How It Works

    Hyperforin is the principal active. Rather than blocking a single transporter, it raises intracellular sodium in the presynaptic terminal, which non-selectively reduces reuptake of serotonin, noradrenaline, dopamine, GABA and glutamate. That broad profile is unlike any prescription antidepressant and may explain the favourable tolerability alongside real efficacy. Hyperforin is also a potent activator of the pregnane X receptor, which upregulates cytochrome P450 3A4 and P-glycoprotein. This is the same molecule driving both the benefit and the interaction problem, so choosing a low-hyperforin extract to reduce interactions also reduces the effect.

    Pathways involved

    Non-selective monoamine reuptake inhibition
    Intracellular sodium elevation via hyperforin
    Pregnane X receptor activation
    CYP3A4 and P-glycoprotein induction
    Hypericin photosensitising activity
    Possible melatonin and circadian effects
    Hypericin, the other named constituent, is the one responsible for photosensitivity. That matters in a seasonal context because light therapy is often used at the same time, and the combination has been reported to increase eye and skin light sensitivity.

    Dosing & Protocol

    ContextDoseFormTiming
    Standard trial dose300 mg three times dailyExtract standardised to 0.3% hypericinWith meals
    Once-daily preparations600-900 mg dailyStandardised extractMorning with food
    Standardisation to look for0.3% hypericin or 3-5% hyperforinStandardised extractStated on the label
    Trial duration4-12 weeks-Assess at 6 weeks
    1. 1

      Review every medication first· Before starting

      List prescriptions, contraceptives and other supplements with a pharmacist or prescriber. This step is not optional with this herb.

    2. 2

      Use a standardised extract at 900 mg daily· Daily

      300 mg three times daily standardised to 0.3% hypericin is the most tested regimen.

    3. 3

      Add morning light exposure· Every morning

      For seasonal mood, bright light within an hour of waking addresses the circadian component directly.

    4. 4

      Assess at six weeks· Week 6

      Use a repeatable mood scale. Taper rather than stop abruptly, since discontinuation symptoms have been reported.

    Contraceptive failure is documented

    St John's wort induces CYP3A4 and has caused breakthrough bleeding and unintended pregnancy in women on hormonal contraception. Use an additional non-hormonal method or choose a different supplement.

    Because the induction effect takes one to two weeks to develop and a similar period to wear off, both starting and stopping can destabilise the drugs it interacts with. Plan the stop as carefully as the start.

    Evidence

    The Cochrane review of St John's wort for major depression pooled a large body of randomised trials and found Hypericum extracts superior to placebo and comparable to standard antidepressants, with fewer participants dropping out for adverse effects. The reviewers flagged a consistent geographic effect: trials from German-speaking countries, where the herb is a mainstream prescription product, reported larger benefits than trials conducted elsewhere. For seasonal mood specifically the evidence thins considerably. The available trials are small, several combined the herb with light therapy so the contributions cannot be separated, and none are of Cochrane-review scale.

    Studies linked to this pairing.

    St John's wort for major depression

    Score: 9/10
    2008
    systematic_review
    n=5489

    Linde K, Berner MM, Kriston L

    St John's wort is effective for mild to moderate major depression with better tolerability than standard antidepressants.

    View source

    St John's wort for major depression

    Score: 9/10
    2008
    systematic_review
    n=5489

    Linde K, Berner MM, Kriston L

    St John's wort was superior to placebo and comparable to standard antidepressants with fewer adverse effects

    View source
    Best available evidence
    Cochrane systematic review in major depression
    Typical effect
    Superior to placebo; comparable to standard antidepressants with fewer adverse effects
    Studied dose
    900 mg daily of standardised extract
    Time to effect
    4-6 weeks
    Main limitation
    Geographic effect-size variation; little seasonal-specific data; major interaction risk

    Safety

    The interaction profile is the main risk

    St John's wort reduces blood levels of many prescription drugs, including immunosuppressants, HIV antiretrovirals, anticoagulants, some chemotherapy agents and hormonal contraceptives, with documented treatment failures. Do not start it without a medication review.

    Common effects

    Photosensitivity of skin and eyes
    Dry mouth
    Gastrointestinal upset
    Restlessness or vivid dreams
    Serotonin syndrome risk with serotonergic drugs
    May trigger mania in bipolar disorder

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Hormonal contraceptives
    high
    CYP3A4 induction lowers hormone levelsAvoid, or use an additional non-hormonal method
    SSRIs, SNRIs, triptans, tramadol
    high
    Additive serotonergic activity, serotonin syndrome riskAvoid combining
    Ciclosporin, tacrolimus, antiretrovirals
    high
    Marked reduction in drug levels; transplant rejection and treatment failure reportedContraindicated
    Warfarin and DOACs
    high
    Induced metabolism reduces anticoagulant effectAvoid
    Light therapy
    moderate
    Hypericin photosensitisationUse eye protection and watch for skin sensitivity
    Because the induction affects a large fraction of commonly prescribed drugs, the safest default is to assume an interaction exists and check, rather than to assume none does. A pharmacist can screen a full medication list in minutes.

    References

    1. Linde K et al. St John's wort for major depression. Cochrane Database Syst Rev. 2008
    2. Nicolussi S et al. Clinical relevance of St John's wort drug interactions revisited. Br J Pharmacol. 2020

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.